Related references
Note: Only part of the references are listed.Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
Esther A. Obeng et al.
CANCER CELL (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
Samar Alsafadi et al.
NATURE COMMUNICATIONS (2016)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
Splicing function of mitotic regulators links R-loop-mediated DNA damage to tumor cell killing
Yihan Wan et al.
JOURNAL OF CELL BIOLOGY (2015)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities
Jian Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
Silvia Xargay-Torrent et al.
ONCOTARGET (2015)
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
Rachel B. Darman et al.
CELL REPORTS (2015)
Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3′ Splice Site Selection in SF3B1-mutated Cancers
Christopher DeBoever et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Genome Modeling System: A Knowledge Management Platform for Genomics
Malachi Griffith et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
T. Okeyo-Owuor et al.
LEUKEMIA (2015)
Myelodysplastic syndromes in the United States: an update for clinicians
Jesse D. Troy et al.
ANNALS OF MEDICINE (2014)
Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
Jeffery M. Klco et al.
CANCER CELL (2014)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Sudemycin E influences alternative splicing and changes chromatin modifications
Paolo Convertini et al.
NUCLEIC ACIDS RESEARCH (2014)
A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
Angela N. Brooks et al.
PLOS ONE (2014)
rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data
Shihao Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Bartlomiej Przychodzen et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Optimization of Antitumor Modulators of Pre-mRNA Splicing
Chandraiah Lagisetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2013)
Ensembl 2013
Paul Flicek et al.
NUCLEIC ACIDS RESEARCH (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Epidemiology of Myelodysplastic Syndromes
Xiaomei Ma
AMERICAN JOURNAL OF MEDICINE (2012)
Mutations affecting mRNAsplicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Frederik Damm et al.
BLOOD (2012)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
Detecting differential usage of exons from RNA-seq data
Simon Anders et al.
GENOME RESEARCH (2012)
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
V. Visconte et al.
LEUKEMIA (2012)
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert et al.
NATURE GENETICS (2012)
The spliceosome as a target of novel antitumour drugs
Sophie Bonnal et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Liying Fan et al.
ACS CHEMICAL BIOLOGY (2011)
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries
Christopher R. Cogle et al.
BLOOD (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Gene ontology analysis for RNA-seq: accounting for selection bias
Matthew D. Young et al.
GENOME BIOLOGY (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al.
NATURE BIOTECHNOLOGY (2008)
Moderated statistical tests for assessing differences in tag abundance
Mark D. Robinson et al.
BIOINFORMATICS (2007)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
